Scale changed the leverage math
The clearest reimbursement effect of consolidation is negotiating scale. A single-site practice negotiates one contract against a national payer's portfolio-level data. A platform spanning dozens of sites negotiates with volume, geographic coverage, and analytics that approach the payer's own. That shift alone can move commercial rates materially, particularly in specialties where the platform controls a large share of a local market.
But scale cuts both ways. The same market concentration that improves leverage also draws antitrust attention, payer network-design responses, and, in hospital-based specialties, the No Surprises Act's constraints on out-of-network billing.
Reimbursement gains from consolidation are durable only when they rest on demonstrated value and clean contracting — not on out-of-network leverage that the No Surprises Act has largely closed.
The No Surprises Act reset the model
Several PE-backed staffing models historically relied, in part, on out-of-network billing for hospital-based services. The No Surprises Act removed the patient from that equation and routed disputes into the Federal Independent Dispute Resolution (IDR) process, anchored to the qualifying payment amount (QPA). For emergency medicine, radiology, anesthesiology, and pathology, that changed the economics of the underlying investment thesis.
The result is a sharper focus on in-network rate strategy, QPA integrity, and disciplined use of IDR — rather than balance-billing leverage — as the path to fair reimbursement.
What payers and regulators are watching
| Area | What draws attention | Reimbursement implication |
|---|---|---|
| Market concentration | High local share in a specialty | Antitrust review; payer network pushback |
| Out-of-network patterns | IDR volume, QPA disputes | Rate compression; administrative cost |
| Coding intensity | Upcoding / modifier patterns | Audit exposure; denials |
| Site-of-service | Facility vs office billing mix | Payer steering; site-neutral pressure |
Illustrative; specifics vary by state, specialty, and payer.
None of these is disqualifying, but each is a place where reimbursement can be gained through discipline or lost through inattention.
A reimbursement thesis that survives diligence
- Underwrite rate on in-network value, not out-of-network optionality.
- Model QPA and IDR exposure explicitly for hospital-based specialties.
- Stress-test the platform against site-neutral and transparency scenarios.
- Build contract-level visibility so post-close integration protects, rather than erodes, negotiated rates.